Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial

10.1038/nm1632

Saved in:

Bibliographic Details
Main Authors:	Patil, S.T., Zhang, L., Martenyi, F., Lowe, S.L., Jackson, K.A., Andreev, B.V., Avedisova, A.S., Bardenstein, L.M., Gurovich, I.Y., Morozova, M.A., Mosolov, S.N., Neznanov, N.G., Reznik, A.M., Smulevich, A.B., Tochilov, V.A., Johnson, B.G., Monn, J.A., Schoepp, D.D.
Other Authors:	INSTITUTE OF MOLECULAR & CELL BIOLOGY
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/114986
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-114986
record_format	dspace
spelling	sg-nus-scholar.10635-1149862023-10-30T07:04:28Z Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial Patil, S.T. Zhang, L. Martenyi, F. Lowe, S.L. Jackson, K.A. Andreev, B.V. Avedisova, A.S. Bardenstein, L.M. Gurovich, I.Y. Morozova, M.A. Mosolov, S.N. Neznanov, N.G. Reznik, A.M. Smulevich, A.B. Tochilov, V.A. Johnson, B.G. Monn, J.A. Schoepp, D.D. INSTITUTE OF MOLECULAR & CELL BIOLOGY 10.1038/nm1632 Nature Medicine 13 9 1102-1107 NAMEF 2014-12-12T07:09:36Z 2014-12-12T07:09:36Z 2007-09 Article Patil, S.T., Zhang, L., Martenyi, F., Lowe, S.L., Jackson, K.A., Andreev, B.V., Avedisova, A.S., Bardenstein, L.M., Gurovich, I.Y., Morozova, M.A., Mosolov, S.N., Neznanov, N.G., Reznik, A.M., Smulevich, A.B., Tochilov, V.A., Johnson, B.G., Monn, J.A., Schoepp, D.D. (2007-09). Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial. Nature Medicine 13 (9) : 1102-1107. ScholarBank@NUS Repository. https://doi.org/10.1038/nm1632 10788956 http://scholarbank.nus.edu.sg/handle/10635/114986 000249353100038 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1038/nm1632
author2	INSTITUTE OF MOLECULAR & CELL BIOLOGY
author_facet	INSTITUTE OF MOLECULAR & CELL BIOLOGY Patil, S.T. Zhang, L. Martenyi, F. Lowe, S.L. Jackson, K.A. Andreev, B.V. Avedisova, A.S. Bardenstein, L.M. Gurovich, I.Y. Morozova, M.A. Mosolov, S.N. Neznanov, N.G. Reznik, A.M. Smulevich, A.B. Tochilov, V.A. Johnson, B.G. Monn, J.A. Schoepp, D.D.
format	Article
author	Patil, S.T. Zhang, L. Martenyi, F. Lowe, S.L. Jackson, K.A. Andreev, B.V. Avedisova, A.S. Bardenstein, L.M. Gurovich, I.Y. Morozova, M.A. Mosolov, S.N. Neznanov, N.G. Reznik, A.M. Smulevich, A.B. Tochilov, V.A. Johnson, B.G. Monn, J.A. Schoepp, D.D.
spellingShingle	Patil, S.T. Zhang, L. Martenyi, F. Lowe, S.L. Jackson, K.A. Andreev, B.V. Avedisova, A.S. Bardenstein, L.M. Gurovich, I.Y. Morozova, M.A. Mosolov, S.N. Neznanov, N.G. Reznik, A.M. Smulevich, A.B. Tochilov, V.A. Johnson, B.G. Monn, J.A. Schoepp, D.D. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
author_sort	Patil, S.T.
title	Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
title_short	Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
title_full	Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
title_fullStr	Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
title_full_unstemmed	Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
title_sort	activation of mglu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/114986
_version_	1781789325221953536

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial

Similar Items